The Latest Cardiac and Vascular News
LONDON and MONTREAL, July 27, 2020 (GLOBE NEWSWIRE) — DalCor Pharmaceuticals today announced that the independent dal-GenE Data and Safety Monitoring Board (DSMB) recommends the dal-GenE pivotal outcomes trial should continue as planned with no modifications. This is an important milestone for DalCor and for cardiovascular patients with the ADCY9 […]
NEW YORK–(BUSINESS WIRE)–Transformative, a healthcare startup whose software predicts sudden cardiac arrest, announced today that it has raised a $1.7 million seed round, led by Tera Ventures. The round includes funding from the Wellcome Trust, which provided Transformative a Healthcare Innovator Award, and from InHealth Ventures, which had previously invested […]
FDA sets PDUFA date of December 30, 2020 BURLINGTON, Mass.–(BUSINESS WIRE)–scPharmaceuticals Inc. (Nasdaq: SCPH), a pharmaceutical company focused on developing and commercializing products that have the potential to optimize the delivery of infused therapies, advance patient care, and reduce healthcare costs, today announced that the U.S. Food and Drug Administration […]
Synchron’s Stentrode is a fully-implantable brain-computer interface being designed to enable people with paralysis to restore functional independence by engaging in activities of daily living SAN FRANCISCO & NEW YORK CITY & MELBOURNE, Australia–(BUSINESS WIRE)–Synchron Inc., a neurovascular bioelectronic medicine company, today announced that the Company has been awarded nearly AUD$1M […]
SUWANEE, GA, July 24, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — SANUWAVE Health, Inc. (OTCQB: SNWV) (“SANUWAVE” or the “Company”) today announced the results from the Company’s 2020 Annual Meeting of Stockholders, held Thursday, July 23, 2020. All director nominees, including Kevin A. Richardson II, John F. Nemelka, Alan L Rubino, A. Michael […]
BURLINGTON, Mass., July 23, 2020 (GLOBE NEWSWIRE) — LeMaitre Vascular, Inc. (Nasdaq:LMAT), a provider of vascular devices, implants and services, today reported Q2 2020 results and announced a $0.095/share quarterly dividend. Q2 2020 Results Sales of $24.9mm, -16% (-24% organic) vs. Q2 2019 Op. income of $4.9mm, -18% Adjusted op. income of $6.1mm, […]
VANCOUVER and MINNEAPOLIS, July 23, 2020 (GLOBE NEWSWIRE) — via NEWMEDIAWIRE — Neovasc Inc. (“Neovasc” or the “Company”) (NASDAQ, TSX: NVCN) announced today that Strul Medical Group LLC (“SMG”) exercised 1,424,049 of the 2,573,959 common share purchase warrants (the “May Warrants”) issued pursuant to a Securities Purchase Agreement dated May […]
BRISBANE, Calif., July 23, 2020 (GLOBE NEWSWIRE) — MyoKardia, Inc. (Nasdaq: MYOK) today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to mavacamten, a novel, oral, allosteric modulator of cardiac myosin, for the treatment of symptomatic, obstructive hypertrophic cardiomyopathy (HCM). The FDA’s Breakthrough Therapy […]
Gordie Nye Succeeds Founder David Fischell as of July 20, 2020. EATONTOWN, N.J., July 23, 2020 /PRNewswire/ — Angel Medical Systems INC is pleased to announce the appointment of Gordie Nye as its new Chief Executive Officer. Gordie succeeds the company’s founder David Fischell, who will become the Chairman of the Board and trusted advisor to […]
IRVINE, Calif., July 23, 2020 /PRNewswire/ — Edwards Lifesciences Corporation (NYSE: EW), the global leader in patient-focused innovations for structural heart disease and critical care monitoring, today reported financial results for the quarter ended June 30, 2020. Second Quarter Highlights and Outlook Sales declined 15% to $925 million; underlying1 sales declined 14% TAVR sales declined […]
